QuanMol Tech

At QuanMol, we are building an AI-powered precision drug design platform that routinizes the discovery of nanomolar-potency compounds. This technology platform enables multiple acceleration opportunities, including the ability to progress to ADMET and PK/PD assays much earlier. Our solutions potentially reduce the overall discovery effort by an additional 25% at only 5-10% of the traditional costs. QuanMol is a member of #EndlessFrontierLabs and #NVIDIAInception. How can we help? ⚛️ If you are a medicinal chemist: Our platform uncovers unique structures and generates in silico SARs, significantly accelerating your projects - as proven by the success of our current collaborators! 🧬 If you are a biologist: Liberate yourself from chemistry challenges by working with our AI-powered medicinal chemistry experts! Our integrated discovery solutions empower you to identify high-potential development candidates with unmatched efficiency at only a fraction of traditional costs. 🔬 If you are a professor in related fields: Join our non-profit academic collaboration programs for projects with novel targets or MOAs. Utilize our latest AI technologies to expand the novelty and efficiency of your research. Our platform solutions are now accelerating nearly 20 discovery programs in diverse therapeutic areas, encompassing both public companies and emerging biotechs. Ready to elevate your research? Learn about how we will work with you by e-mailing connect@quanmol.com - Let's make friends!